コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 iption factors such as NF-kappaB, C/EBP, and serum response factor.
2 of nuclear factors of activated T cells and serum response factor.
3 ophy, likely by its direct interactions with serum response factor.
4 ing transcription factor, NF-kappaB/Rel, and serum response factor.
5 ly regulated by TGF-beta1/SMAD and myocardin/serum response factor.
6 h muscle gene expression by associating with serum response factor.
7 actin cytoskeletal dynamics, by coactivating serum response factor.
8 ering the displacement of myocardin from the serum-response factor.
9 absence of ELK1 binding partners, ERK1/2 and serum-response factor.
11 scle-specific transcriptional coactivator of serum response factor, a ubiquitous transcription factor
12 lial tumours, and that, in this context, Mal/serum response factor activation is rate-limiting for tu
13 pe Galpha13, Galpha13K204A induced much less serum-response factor activation when expressed in HeLa
14 anically-induced stimuli with the control of serum response factor activity and localization through
16 We found that leupaxin forms a complex with serum response factor and associates with CArG-containin
18 The CArG box is activated by the binding of serum response factor and its coactivators, myocardin (M
19 CYA-depleted cells depended on activation of serum response factor and its cofactors, myocardial-rela
21 rough the CArG box-binding proteins, such as serum response factor and members of the myocardin (Myoc
23 erentiation through the transcription factor serum response factor and the signaling effector calcine
25 (cAMP response element binding factor), SRF (serum response factor), and MEF2 (myocyte enhancer facto
26 TAATC(C/T) cis-element, by interacting with serum response factor, and by increasing histone acetyla
27 ith Brg1 of the SNF/SWI complexes, recruited serum response factor, and remodeled smooth muscle targe
28 iate with the MADS box transcription factor, serum response factor, and synergistically activate tran
30 ding sites for muscle regulatory factors and serum response factor as well as a conserved homeodomain
31 ly all smooth muscle genes are controlled by serum response factor binding sites in their promoter re
33 VSMC contractile genes as well by increasing serum response factor binding to CArG-containing regions
34 nce inhibits Rho-induced gene expression via serum response factor but has no apparent effect on Rho-
36 yocardin (Myocd), a known CArG box-dependent serum response factor coactivator, participates in Smad3
37 myocardin, revealing unique roles for these serum response factor coactivators in the development of
39 odulation of the subcellular localization of serum response factor cofactors is 1 mechanism by which
40 ex factors (TCFs; SAP-1, Elk-1, and Net) are serum response factor cofactors that share many function
42 CC(A/T)6GG-dependent (CArG-dependent) and serum response factor-dependent (SRF-dependent) mechanis
43 otein localized to the Z disc that activates serum response factor-dependent (SRF-dependent) transcri
45 gnals to the nucleus, activating a subset of serum response factor-dependent genes promoting myogenic
47 ilent cardiac myocyte chromatin and directed serum response factor-dependent smooth muscle gene activ
49 rexpression of SOCS-3 specifically increased serum response factor-driven transcriptional activity bu
50 tin polymerization-controlled coactivator of serum response factor, drives myofibroblast transition f
51 , we found that larval glia are enriched for serum response factor expression, explaining the apparen
54 ics approach to investigate the role of SRF (serum response factor) in the serum response of fibrobla
56 es apoptotic engulfment, and determined that serum response factor is important for MFG-E8 production
57 second transcription factor that is probably serum response factor, is located within the first intro
58 ions ablated receptor-mediated activation of serum response factor luciferase, a classic measure of G
59 ctin assembly and microtubule stabilization, serum response factor-mediated gene expression, cell-cyc
62 itous myocardin-related transcription factor/serum response factor (MRTF-A/SRF) transcription pathway
63 t the Myocardin-related transcription factor/Serum response factor (MRTF/SRF) pathway plays a key rol
64 The myocardin-related transcription factor/serum response factor (MRTF/SRF) pathway represents a pr
66 nding sites for three transcription factors, serum response factor, myelin transcription factor-1, an
67 d in vivo induces the expression of the SRF (serum response factor), myocardin, and MRTFA (myocardin-
68 R-143 were direct transcriptional targets of serum response factor, myocardin and Nkx2-5 (NK2 transcr
69 ression and promoting the association of the serum response factor-myocardin complex with VSMC contra
70 ansactivated the Bmp10 gene via binding of a serum response factor-myocardin protein complex to a non
71 tion, through signaling events targeting the serum response factor-myocardin-related transcription fa
72 gulating myocardin expression and preventing serum response factor/myocardin from associating with SM
74 targets of RhoA and Rac1 signaling including serum response factor, NF-kappaB, and other transcriptio
75 nscriptional activity of Stat3, NFkappaB, or serum response factor, nor the expression of the cell di
76 or three positive transcription factors, the serum response factor, Oct-1, and myocyte enhancer facto
77 stingly, FHL2 does not affect recruitment of serum response factor or Myocd, however, it inhibits rec
79 -SRF (myocardin-related transcription factor-serum response factor) pathway for sustained PM blebbing
81 iac myocyte hypertrophy is modulated by SRF (serum response factor) phosphorylation, constituting an
83 AR along with the transcription factor SRF (serum response factor), representing less than 6% of and
84 based assays, including Ca(2+) mobilization, serum response factor response element, stress fiber for
85 ownstream effector, the transcription factor serum response factor resulted in analogous developmenta
86 o and in transgenic mice increased myocardin/serum response factor signaling and increased expression
87 reased levels of cellular ATP, and increased serum response factor signaling in primary fibroblasts,
89 ent is critically dependent on a RAF/MEK/ERK/serum response factor signaling pathway and suggest that
90 f the myocardin-related transcription factor/serum response factor signaling pathway as a therapeutic
95 P-response element binding protein CREB, the serum response factor SRF, and the nuclear factor of act
96 orylation of a cluster of amino acids in the serum response factor (SRF) "MADS box" alphaI coil DNA b
98 ber et al. identify actin polymerization and serum response factor (SRF) activation as key steps link
101 ly identified that the transcription factor, serum response factor (SRF) and a number of its target g
102 ntractility and motility by associating with serum response factor (SRF) and activating genes involve
103 factor-responsive transcription cofactors of serum response factor (SRF) and are activated by MAP kin
104 at Tip60alpha, Tip60beta, and Tip55 can bind serum response factor (SRF) and by transient transfectio
106 ein-2 (FHL2) and FHL2-mediated inhibition of serum response factor (SRF) and extracellular signal-reg
107 ction, because it acted synergistically with serum response factor (SRF) and GATA6 to activate the SM
110 ecent studies have shown that interaction of serum response factor (SRF) and its numerous accessory c
111 CBF regulation, express in AD high levels of serum response factor (SRF) and myocardin (MYOCD), two i
112 required for SMC differentiation, including serum response factor (SRF) and myocardin family members
114 stigated the combinatorial role of myocardin/serum response factor (SRF) and Notch signaling in the t
115 oLSD1 can interact with transcription factor serum response factor (SRF) and set the chromatin state
116 -related transcription factor A (MRTF-A) and serum response factor (SRF) and the other using the tran
118 n promoter and Elk-1 binding is dependent on serum response factor (SRF) binding to a nearby CArG box
119 romatin immunoprecipitation assays confirmed serum response factor (SRF) binding to both CArG element
122 or transcriptional synergy between GATA4 and serum response factor (SRF) but not other cardiac cofact
124 cAMP-induced cytoskeletal remodelling on the serum response factor (SRF) co-factors Megakaryoblastic
127 We previously reported the importance of the serum response factor (SRF) cofactor myocardin in contro
128 proteins (myocardin, MRTF-A, and MRTF-B) are serum response factor (SRF) cofactors and potent transcr
129 in-related transcription factors (MRTFs) are serum response factor (SRF) cofactors that promote a smo
134 in part from TGFbeta-induced enhancement of serum response factor (SRF) DNA binding and transcriptio
135 n factors megakaryoblastic leukemia-1 (MKL1)/serum response factor (SRF) during myofibroblast differe
136 e extreme thrombocytopenia than mice lacking serum response factor (SRF) expression in the megakaryoc
137 We tested the idea that T-box factors direct serum response factor (SRF) gene activity early in devel
142 s, we found a potential binding site for the serum response factor (SRF) in the promoter of the ubiqu
143 transcription factors (MRTFs) co-activating serum response factor (SRF) in this process is largely u
160 uitously expressed transcriptional regulator serum response factor (SRF) is controlled by both Ras/MA
162 element (SRE)-mediated gene expression, and serum response factor (SRF) is indispensable for SRE-med
167 ER alpha binding sites, constitutively bound serum response factor (SRF) mediates estrogen stimulatio
170 tion of the FHL2 gene, mediated by action of serum response factor (SRF) on its proximal promoter.
175 n in vascular smooth muscle cells (VSMCs) by serum response factor (SRF) plays a crucial role in vasc
178 genomic approaches, we provide evidence that serum response factor (SRF) regulates both general and c
181 yocardin-related transcription factor (MRTF)-serum response factor (SRF) regulatory axis within stria
183 have shown that neuron-specific deletion of serum response factor (SRF) results in deficits in tange
184 p38 mitogen-activated protein kinase (MAPK) serum response factor (SRF) signaling via the TRPC6 prom
185 ith multiple actin regulators and to promote serum response factor (SRF) signalling has raised the qu
186 n is an extraordinarily powerful cofactor of serum response factor (SRF) that stimulates expression o
187 og, NKX2.5, NKX3.1 acts synergistically with serum response factor (SRF) to activate expression from
188 ors (TCFs) act with the transcription factor serum response factor (SRF) to activate mitogen-induced
189 of TNF-alpha-induced NF-kappaB and myocardin/serum response factor (SRF) to convey hypertrophy signal
190 e to actin polymerization and cooperate with serum response factor (Srf) to regulate the expression o
191 22alpha promoter by hindering the binding of serum response factor (SRF) to the proximal CArG box.
192 n state dictates the interaction between the serum response factor (SRF) transcription factor and one
193 1) is a myocardin-related coactivator of the serum response factor (SRF) transcription factor, which
194 aryoblast leukemia 1 (MKL1), an activator of serum response factor (SRF) transcriptional activity, pr
198 in embryos with cardiac-specific ablation of serum response factor (SRF), a direct transcriptional re
200 of MRTFs to the nucleus where they activate serum response factor (SRF), a regulator of actin and ot
201 These changes are largely controlled by the serum response factor (SRF), a transcription factor that
202 d lamellipodin share the ability to activate serum response factor (SRF), a transcription factor that
203 tal actin signals physically associates with serum response factor (SRF), activating a subset of SRF-
204 distintegrin and metalloprotease family 10), serum response factor (SRF), and insulin-like growth fac
205 r-related, locus 5 (NKX2-5), T-box 5 (TBX5), serum response factor (SRF), and myocyte-enhancer factor
206 the c-fos cellular oncogene is regulated by serum response factor (SRF), and Tax is known to induce
207 iscernible CArG motifs, the binding site for serum response factor (SRF), and we show that the enhanc
208 the activity-dependent transcription factor, serum response factor (SRF), as a novel upstream mediato
209 ether myocardin, a SMC-selective cofactor of serum response factor (SRF), contributed to Ang II-induc
210 response element binding protein (CREB) and serum response factor (SRF), in mediating this induction
211 the stimulus-dependent transcription factor, serum response factor (SRF), in neural precursor cells (
212 ile gene transcription factors myocardin and serum response factor (SRF), independent of mammalian ta
213 (MYOCD), a cardiac-specific co-activator of serum response factor (SRF), is increased in DCM porcine
214 diated by the MADS-box transcription factor, serum response factor (SRF), its actin-binding myocardin
215 Ablation of KLF3, known to interact with serum response factor (SRF), or SRF itself, results in f
216 the stimulus-dependent transcription factor, serum response factor (SRF), plays a critical role in re
217 TEAD1 competes with myocardin for binding to serum response factor (SRF), resulting in disruption of
218 ecific depletion of the transcription factor Serum Response Factor (SRF), suffer from loss of BBB int
219 cription factor-A (MRTF-A), a coactivator of serum response factor (SRF), we discovered a muscle-enri
220 ripts is the nodal transcriptional regulator serum response factor (SRF), whereas another is calcineu
221 ir differentiation state can be regulated by serum response factor (SRF), which activates genes invol
222 via RhoA, conveys androgen-responsiveness to serum response factor (SRF), which controls aggressive C
223 n factor that functions as a coactivator for serum response factor (SRF), which controls genes involv
224 of smooth muscle (SM) cells is controlled by serum response factor (SRF), which drives the expression
225 ocardin is a transcriptional co-activator of serum response factor (Srf), which is a key regulator of
226 fferentiation is mediated by the activity of serum response factor (SRF), which is tightly controlled
227 RTFs) MRTF-A and MRTF-B are coactivators for serum response factor (SRF), which regulates genes invol
230 transcriptional coactivator that activates a serum response factor (SRF)-dependent gene program requi
231 l activation in response to mitogens through serum response factor (SRF)-dependent recruitment of Elk
234 Here we report that Galphaz signals inhibit serum response factor (SRF)-dependent transcription.
235 e second is a cryptic degron adjacent to the serum response factor (SRF)-interaction domain that mark
236 cription factors (MRTFs) are coactivators of serum response factor (SRF)-mediated gene expression.
237 ellular F-actin/G-actin levels also regulate serum response factor (SRF)-mediated gene regulation, su
238 induce activation of Rho GTPase, leading to serum response factor (SRF)-mediated gene transcription
239 yocardin-related transcription factor (MRTF)/serum response factor (SRF)-mediated gene transcription
241 uced nuclear actin polymerization results in serum response factor (SRF)-mediated transcription throu
242 tiation, we screened for TGF-beta1 and MYOCD/serum response factor (SRF)-regulated TSPANs in VSMC by
268 marker expression and promoter activity in a serum response factor (SRF)/CArG box-dependent manner.
269 ll-restricted genes governed directly by the serum response factor (SRF)/myocardin (MYOCD) transcript
271 ptional control by the transcription factor, serum response factor (SRF); however, the mechanisms dyn
272 SMA) is mediated by the transcription factor serum-response factor (SRF) along with its co-activator,
274 (MRTFs), through their interaction with the serum-response factor (SRF) on CArG box regulatory eleme
276 ion corresponded with elevated expression of serum-response factor (SRF), a master regulator of mitog
277 In addition, PKN increased the activities of serum-response factor (SRF), GATA, and MEF2-dependent en
278 nscription factor (MRTF)-A, a coactivator of serum-response factor (SRF), known to promote fibroblast
279 A/MAL/MKL1/BSAC) regulates the expression of serum-response factor (SRF)-dependent target genes in re
280 ), which directly binds actin and stimulates serum-response factor (SRF)-dependent transcription.
285 mechanism for fine tuning the expression of serum response factor target genes in a gene-specific ma
287 nteracts with Pico, and, Mal, a cofactor for serum response factor that responds to changes in G:F ac
288 transcriptional coactivators cooperate with serum response factor to activate smooth muscle gene exp
289 f transcriptional coactivators that bind the serum-response factor to activate gene expression progra
290 binding of the sequence-specific factor Srf (serum response factor) to Egr1 regulatory sites is depen
291 in the context of cardiac hypertrophy, where serum response factor transactivation is a key event nec
292 of dilated cardiomyopathy (DCM) triggered by Serum Response Factor transcription factor depletion in
293 ers cofilin phosphorylation, F-actin levels, serum response factor transcriptional activity and colla
295 143/145 was dependent upon the myocardin and serum response factor transcriptional switch as well as
296 ular smooth muscle phenotype is regulated by serum response factor, which is itself regulated in part
298 tors (MRTFs) A and B act as coactivators for serum response factor, which plays a key role in cardiov
299 ption factor A (MRTF-A), is a coactivator of serum response factor, which regulates transcription of
300 ced stress fiber formation and activation of serum response factor without affecting Smad signaling.